Abdulkader Puranwala
Stock Analyst at ICICI Securities
(3.05)
# 2,532
Out of 4,411 analysts
40
Total ratings
65.4%
Success rate
6.6%
Average return
Main Sectors:
Stocks Rated by Abdulkader Puranwala
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NSE: ALKEM Alkem Laboratories Limited | Maintained: Buy | ₹6,065 → ₹6,850 | $5,347.00 | +28.11% | 4 | May 28, 2026 | |
| NSE: APOLLOHOSP Apollo Hospitals Enterprise Limited | Maintained: Buy | ₹8,840 → ₹8,820 | $8,400.00 | +5.00% | 3 | Feb 12, 2026 | |
| NSE: GLENMARK Glenmark Pharmaceuticals Limited | Maintained: Sell | ₹1,570 → ₹1,640 | $2,158.00 | -24.00% | 3 | Feb 3, 2026 | |
| NSE: GLAND Gland Pharma Limited | Maintained: Buy | ₹2,115 → ₹2,275 | $2,174.00 | +4.65% | 2 | Jan 29, 2026 | |
| NSE: AKUMS Akums Drugs and Pharmaceuticals Limited | Maintained: Buy | ₹655.00 → ₹600.00 | $600.35 | -0.06% | 3 | Dec 22, 2025 | |
| NSE: SUNPHARMA Sun Pharmaceutical Industries Limited | Maintained: Buy | ₹1,800 → ₹1,965 | $1,805.00 | +8.86% | 2 | Nov 6, 2025 | |
| NSE: NATCOPHARM NATCO Pharma Limited | Maintained: Sell | ₹890.00 → ₹810.00 | $851.90 | -4.92% | 2 | Aug 14, 2025 | |
| NSE: METROPOLIS Metropolis Healthcare Limited | Maintained: Buy | ₹2,400 | $535.15 | +348.47% | 1 | Aug 11, 2025 | |
| NSE: FORTIS Fortis Healthcare Limited | Upgraded: Hold | ₹855.00 | $969.40 | -11.80% | 1 | Aug 8, 2025 | |
| NSE: KIMS Krishna Institute of Medical Sciences Limited | Downgraded: Sell | ₹630.00 | $779.90 | -19.22% | 2 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | ₹5,400 | $6,730.00 | -19.76% | 1 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | ₹2,110 → ₹1,950 | $2,272.60 | -14.20% | 2 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | ₹900.00 | $747.00 | +20.48% | 1 | Aug 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | ₹1,445 → ₹1,300 | $1,402.00 | -7.28% | 2 | Aug 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | ₹590.00 | $627.90 | -6.04% | 1 | Aug 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | ₹2,900 → ₹1,500 | $1,645.00 | -8.81% | 2 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | ₹1,000 | $1,298.60 | -22.99% | 2 | Jul 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | ₹910.00 → ₹486.62 | $535.90 | -9.20% | 2 | Jul 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | ₹1,200 | $1,277.50 | -6.07% | 1 | Jul 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | ₹1,400 | $432.60 | n/a | 1 | Mar 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | ₹2,250 | $2,197.10 | n/a | 1 | Feb 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | ₹1,000 | $1,080.80 | n/a | 1 | Feb 6, 2025 |
Alkem Laboratories Limited
May 28, 2026
Maintained: Buy
Price Target: ₹6,065 → ₹6,850
Current: $5,347.00
Upside: +28.11%
Apollo Hospitals Enterprise Limited
Feb 12, 2026
Maintained: Buy
Price Target: ₹8,840 → ₹8,820
Current: $8,400.00
Upside: +5.00%
Glenmark Pharmaceuticals Limited
Feb 3, 2026
Maintained: Sell
Price Target: ₹1,570 → ₹1,640
Current: $2,158.00
Upside: -24.00%
Gland Pharma Limited
Jan 29, 2026
Maintained: Buy
Price Target: ₹2,115 → ₹2,275
Current: $2,174.00
Upside: +4.65%
Akums Drugs and Pharmaceuticals Limited
Dec 22, 2025
Maintained: Buy
Price Target: ₹655.00 → ₹600.00
Current: $600.35
Upside: -0.06%
Sun Pharmaceutical Industries Limited
Nov 6, 2025
Maintained: Buy
Price Target: ₹1,800 → ₹1,965
Current: $1,805.00
Upside: +8.86%
NATCO Pharma Limited
Aug 14, 2025
Maintained: Sell
Price Target: ₹890.00 → ₹810.00
Current: $851.90
Upside: -4.92%
Metropolis Healthcare Limited
Aug 11, 2025
Maintained: Buy
Price Target: ₹2,400
Current: $535.15
Upside: +348.47%
Fortis Healthcare Limited
Aug 8, 2025
Upgraded: Hold
Price Target: ₹855.00
Current: $969.40
Upside: -11.80%
Krishna Institute of Medical Sciences Limited
Aug 8, 2025
Downgraded: Sell
Price Target: ₹630.00
Current: $779.90
Upside: -19.22%
Aug 7, 2025
Maintained: Sell
Price Target: ₹5,400
Current: $6,730.00
Upside: -19.76%
Aug 7, 2025
Maintained: Hold
Price Target: ₹2,110 → ₹1,950
Current: $2,272.60
Upside: -14.20%
Aug 6, 2025
Maintained: Hold
Price Target: ₹900.00
Current: $747.00
Upside: +20.48%
Aug 6, 2025
Upgraded: Buy
Price Target: ₹1,445 → ₹1,300
Current: $1,402.00
Upside: -7.28%
Aug 5, 2025
Maintained: Hold
Price Target: ₹590.00
Current: $627.90
Upside: -6.04%
Aug 1, 2025
Maintained: Hold
Price Target: ₹2,900 → ₹1,500
Current: $1,645.00
Upside: -8.81%
Jul 29, 2025
Maintained: Sell
Price Target: ₹1,000
Current: $1,298.60
Upside: -22.99%
Jul 25, 2025
Maintained: Buy
Price Target: ₹910.00 → ₹486.62
Current: $535.90
Upside: -9.20%
Jul 24, 2025
Maintained: Hold
Price Target: ₹1,200
Current: $1,277.50
Upside: -6.07%
Mar 25, 2025
Initiated Coverage: Buy
Price Target: ₹1,400
Current: $432.60
Upside: n/a
Feb 17, 2025
Upgraded: Buy
Price Target: ₹2,250
Current: $2,197.10
Upside: n/a
Feb 6, 2025
Maintained: Hold
Price Target: ₹1,000
Current: $1,080.80
Upside: n/a